New role for the IMA in 2021

New roles

With the new Medicinal Products Act No. 100/2020 coming into
force the IMA has taken on new roles which are as follows:

  • to determine maximum price for prescription
    medicinal products both at wholesale and retail level
  • to determine maximum price for all veterinary
    medicinal products both at wholesale and retail level (both prescription and
    over the counter medicinal products)
  • to determine if a medicinal product falls under
    reimbursement and determine the reimbursement price
  • to determine if a medicinal product is qualifies
    as a Specialty care high-cost medinal product
  • to determine if an unlicensed medicinal product
    which is listed in the Named Patient Program (NPP) falls under reimbursement.

Inquiries on the aforementioned roles should be sent to [email protected].

Information dissemination

All communication concerning the aforementioned roles will
be performed by the IMA on or after 1st of January 2021.

Disclaimer
and copyright

Var efnið hjálplegt Yes No

Hvað þarf að laga?